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Abstract 
Background: Long-term sickness absence is a growing con-
cern in Belgium and other European countries. Since 2017,
Belgian physicians of the sickness funding organisations are
required to assess the re-integration possibilities within the first
two months of sickness absence. Given the shortage of physicians
in the assessment of work disability and the growing number of
people in sickness absence, there is a need for a triage tool, allow-
ing to assign return-to work support to patients having a high-risk
profile not to resume work.
Methods/design: The current study comprises a comprehen-
sive validation process of a screening tool that supports Belgian
physicians in guiding people back to work. The study consists of
a theoretical construct validation (face validity and content valid-
ity), and an empirical construct validation (concurrence validity,
factorial validity, predictive validity, hypothesis testing validity
and known- group validity).
Expected impact of the study for Public Health: The screening
instrument assessing the risk for long-term sickness absence is a
tool developed to support physicians who work for sickness funds
and for occupational health and safety organisations. Both profes-
sionals play an important role in the return to work process and the
prevention of long-term sickness absence. The screening tool aims
at making a distinction between people who will resume their
work independently and people who will need support to do so.
Generation of this prediction model will help physicians to focus
effort and resources in the high-risk group. Results may also help
understand the relationship between the biopsychosocial model
and long-term sick-leave.
Introduction
Long-term sickness absence − defined as absence from work
longer than six months due to sickness − is increasing in the 27
European member states and Norway.1 The Organization for
Economic Co-operation and Development (OECD) estimates the
costs of disability and sickness to be 2.5 times higher than those
of unemployment.1 Sickness absence is not only costly for the
organization and for society, but also for the individual. Previous
studies have shown that long-term sickness absence is a prognos-
tic marker of even more future absence from work, early retire-
ment due to ill health and mortality. Long-term sickness absence
can also be associated with future unemployment, financial diffi-
culties, psychological problems, and social exclusion.2
Therefore, several countries have taken initiatives to decrease
long-term sickness absence, and lower the costs related to disabil-
ity and sickness. However, despite the growing interest in decreas-
ing sickness absence across Europe and many countries that
implement promising projects, it remains challenging to dedicate
the resources to the people that need it most, i.e. sick listed
employees with a high risk of not returning to work. Hence, most
sick listed employees are returning to work spontaneously within
six weeks and do not need additional support.3 Existing instru-
ments do not make a clear distinction between employees who
will spontaneously return to work and employees who have a high
risk of long-term sickness absence. Early intervention is key,
because it is widely acknowledged that the longer an employee is
off work, the smaller his chances of ever returning to work.4
Above this, most countries have to deal with great shortage of
physicians who judge disability for sickness fund organisations
and insurance companies.5
Currently, many initiatives are taken worldwide. In Belgium,
new legislation urges physicians of sickness fund organisations
and insurance companies to make a first estimation about re-inte-
gration possibilities about every patient before two months of
sickness absence. In addition, a close cooperation with the occu-
pational health physician is advised in this legislation. A screening
method to detect high risk of long-term sickness absence among
the large group of sick employees might thus be a useful contribu-
tion to support both physicians to meet the requirements of the
new legislation. As such, resources (e.g. money, services) can be
provided in a more efficient way, and the return to work process
of employees at high risk can start much earlier. 
In this context, the present study is planned as a part research
project with the objective to develop and validate a new, more
generic questionnaire that is applicable in all contexts to predict
long-term sickness absence. The construction of the instrument,
more specifically selecting and combining scales, has already
been executed in a previous study. In the current study, we will
Significance for public health
In this research, we tested a generic instrument to screen for long-term sick-
ness absence, regardless the cause of the sickness absence or the political
context. Both biomedical factors and psychosocial factors (such as the
patients’ own prediction) are questioned in the prediction model, which is
thus adapted to the modern view on sick leave. A screening method to detect
high risk of long-term sickness absence among the large group of sick
employees might help to use resources (e.g. money, services) in a more effi-
cient way. Physicians will be able to focus on patients with a high risk on
long-term sick leave, and the return to work process of employees at high
risk can start much earlier. The instrument will, next to the physicians’ prog-
nosis, offer support in prioritizing patients’ files. Hence, a lot of patients will
resume their work spontaneously. Patients who need support will experience
shorter follow-up periods, and better quality of care. In addition, the relation-
ship between predicting factors of the biopsychosocial model and long-term
sickness absence will be examined.
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perform a complete validation of the questionnaire, testing both the
theoretical and empirical construct validity, according to a valida-
tion model.6
Informed consents are available for insight and were approved
by the ethical committee responsible for the project.
Materials and Methods
Aims and objectives
The main objective of this study is to evaluate the validity of a
new screening instrument, aiming to prevent long-term sickness
absence. 
Patients will complete the questionnaire after six weeks of sick
leave in order to make a first assessment about their risk for long-
term sick leave. The goal is to screen patients for their risk on long-
term sick leave. This way, the physician can focus on the high-risk
population and thanks to the content of the questionnaire, the
physician will possess more information about the opportunities
and threats in the work resumption process. The instrument is
available through an online platform, allowing patients to complete
it at home. Afterwards, results are immediately shared with the
patient, and the responsible physician of the sickness benefits
organisation. After both the validation and implementation pro-
cess, the patient will also be able to share the results with his gen-
eral practitioner and his occupational health physician (optional). 
The following questions will be addressed:
- Is the screening tool valid to predict long-term sickness
absence according to patients who experience(d) long-term
sick leave. Are there predicting factors that should be added or
removed from the questionnaire? 
- Is the screening tool a valid measure for long-term sickness
absence when compared to the occupational health physicians’
estimation of the probability of work resumption? 
- What is the internal validity of the different scales of the ques-
tionnaire? Are the scales valid in different populations (occu-
pational and insurance medicine)?
- Is the screening tool a valid predictor of long-term sickness
absence using the actual time until work-resumption as a refer-
ence? 
- What does the screening tool predict about the time until work-
resumption for cancer patients? Does this converge with find-
ings from other studies about cancer patients?
- Is the screening tool able to confirm hypothesis about sickness
absence based on scientific evidence (e.g. higher risk for cer-
tain professions)?
Outcome measures
The primary outcome is time until work-resumption. This out-
come will be identified through different kinds of measures: a sub-
jective estimation of the occupational health physician, an objec-
tive registration of the actual time until resumption, the patients’
estimation of time until work resumption, hypothesis about return
to work in cancer patients and hypothesis based on the Belgian
statistics about long-term sick leave. 
Data collection
In total, three data samples will be collected to perform the val-
idation. 
The first data sample will be collected by inviting patients to
five focus groups on different locations in Belgium. The patients
will be invited using the network of the researchers and using the
network of both Dutch and French patient organisations. Both
patient organisations will spread the invitation to their connected
organisations and to the patients in their network.
The second data sample will be collected by inviting occupa-
tional health physicians to participate in the study. The invite will
be sent by the researchers themselves and by CoPrev, the umbrella
organisation of all external health and safety services in Belgium.
The recruited occupational health physicians on their turn will
recruit patients for the study who are in sick leave and who come
for a consult concerning return to work. After a period of three
weeks, the physicians sent all questionnaires back to the
researchers by regular mail. All questionnaires will be scanned
using special scanning software.  
The third data sample will be collected sending the question-
naires via all sickness fund organisations to all patients who are in
sick leave for six weeks. The patients will receive an invite (either
by regular mail or by email) in which they are asked to use the
electronic available platform to fill in the questionnaire. A
helpdesk is foreseen. After the data collection, the work resump-
tion data of all participants will be collected via the sickness fund
organisations. A random code is used for every patients file to reas-
sure that the researchers never know patients’ identities. The sick-
ness fund organisations sent all work-resumption dates to the
researchers who will put them together in the database. Two inclu-
sion periods are foreseen (6 and 6 weeks).
The data collected throughout the validation process will be
saved either on the servers of KULeuven (qualitative analysis and
patients sample 1), or on the servers of the sickness funds organi-
sations (patients sample 2) (Figure 1). From both sample 1 and 2
all directly identifiable personal data (name, social security num-
ber, address etc.) is replaced by a unique ID-number before data
are sent to the Research group. Researchers are never able to iden-
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Figure 1. Research process flow.
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tify patients thorough the research process. In the qualitative
research project, the researchers know the identity of the patients.
An informed consent assures the patients that no personal data will
be spread in any case. The personal data of the patients (name and
e-mail address) are stored at secured KULeuven servers. 
Study design
One of the most common tasks often encountered in social sci-
ence research is ascertaining the validity and reliability of a mea-
surement tool.7 Researchers always wish to know if the measure-
ment tool actually measures the intended research concept or con-
struct (is it valid? or true measures?) or if the measurement tools
used to quantify the variables provides stable or consistent
responses (is it reliable? or repeatable?). 
As simple as this may seems, it is often omitted or just men-
tioned passively in the research proposal or report.7 This has been
adduced to the dearth of skills and knowledge of validity and reli-
ability test analysis among social and health science researchers. In
this research the psychometric quality is therefore studied very
extensively. 
The study design is presented in Figure 1 was inspired by the
validation framework of Bolarinwa and colleagues.6 Figure 2
depicts the various types of validity that should be tested to support
the psychometric evidence of the screening tool.6
As we aim to validate our screening tool, we will conduct var-
ious studies. All validation studies are marked in rectangles in
Figure 1. The triangle on top of it shows which patient sample was
used to conduct the test (1, 2 or 3). Both the theoretical and the
empirical construct will be validated as described by Bolarinwa
and will be performed simultaneously.6
Development of the screening instrument
The development process of the screening tool for long-term
sickness absence was based on two approaches: a literature review
followed by a snowball sampling technique to address the follow-
ing research questions: i) Which are the predictors for long-term
sickness absence? ii) Which questionnaires measure these predic-
tors for long-term sickness absence in a valid and reliable manner?
To answer the first research question and to determine the in-
and exclusion criteria and search string a PICO strategy (popula-
tion, intervention, comparison and outcome) was applied:
Population: active population (18-65y), Long-term sickness
absence (invalidity, incapacity), Different conditions who are at the
cause of the sickness absence; musculoskeletal disorders, mental
disorders, heart conditions and colon cancer, Predictors, Outcome:
return to work/not (part-time, fulltime, with/without support). The
search inquiries were run in the scientific databases Medline and
Scopus.
Exclusion criteria were: children, adolescents, elderly, persons
with an intellectual disability, other specific disorders, descriptions
of interventions or rehabilitation programs, an evaluation of the
efficiency of interventions or rehabilitation programs, an evalua-
tion of a treatment. 
For the first research question, the search retrieved 998 publi-
cations in Medline and 247 in Scopus. After removal of duplicates,
a total of 1010 publications were retained. After reading the title,
abstract and full text, 53 publications were selected. In total, 21
predictors were found in literature, which were assigned to four
categories: stressful life events, work-related factors, person relat-
ed factors and functioning factors.
To address the second research question, a snowball sampling
technique was used to identify existing questionnaires. Snowball
sampling (also known as chain-referral sampling) is a non-proba-
bility (non-random) sampling method used when sample charac-
teristics are rare and difficult to find. This sampling method
involves primary data sources nominating another potential pri-
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Figure 2. Graphical representation of the subtypes of various forms of validity tests.
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mary data source to be used in this research. In other words, snow-
ball sampling method is based on referrals from initial subjects to
generate additional subjects.8 We applied the snowball sampling
method, because we wanted to include grey literature sources
about (non-published) best practices in our study. 
There are different kinds of snowball sampling. In this
research, exponential non-discriminative snowball sampling was
conducted. The first subject recruited to the sample group provides
multiple referrals. Each new referral is explored until primary data
from sufficient amount of samples are collected.8
The inclusion criteria were: a questionnaire about at least one
factor that predicts long-term sickness absence (out of the 21 fac-
tors we found in literature). The exclusion criteria were: covering
more than one disease and if the questionnaire was a long-form
then the short form was taken.
The snowball sampling started at two points: six question-
naires from the literature review of phase 1 were retained and three
questionnaires from the grey literature. The exponential non-dis-
criminative snowball sampling was conducted by an examination
of all sources of the articles concerning each questionnaire. The
selected sources from the articles are entered in PubMed and a
search for ‘similar articles’ was performed to screen the literature
in a systematic way.
Finally, the results of both search strategies were compiled. 
Participants, recruitment, inclusion and exclusion
The participant’s recruitment depends on the phase of the
research process. The initial screening instrument was based on lit-
erature and existing questionnaires, which did not require patient
participation. As mentioned earlier, three main patient samples will
be collected to conduct five out of six validation tests. The sixth
validation test will be performed using data from a cooperative
research project. We describe the recruitment process of all three
samples in the next section.
In view of the qualitative evaluation (content and face validi-
ty), patients will be recruited to participate in focus groups via
patient organisations, and social network sites. Eligible patients are
at working age (18-65y) and have experienced at least six weeks of
sickness absence. For the second and third part of the validation
process, (factorial and concurrence validity) patients were selected
via occupational health physicians. Several occupational health
physicians were asked to include every patient whose consult con-
cerned return-to-work support, during an inclusion period of six
weeks. The inclusion criteria for the patients were: 1) being on sick
leave, 2) made an appointment with an occupational physician to
discuss re-integration, and 3) French or Dutch speaking. Exclusion
criteria were: 1) Not receiving sickness benefits, 2) having an
appointment with the occupational physician for any other reason
than discussing re-integration, 3) not speaking French or Dutch. 
For the other parts of the validation (predictive and hypothesis-
testing) a third sample of patients will be recruited. All sickness
fund organisations will send the questionnaire to every patient who
reaches the 7th week of sick leave. The recruitment period will
cover 6 weeks for the first period and 4 weeks for the second peri-
od. Working in two periods is designated because practical issues
with the new online platform can be solved in the meantime. For
example; if people are asking the same questions about where to
fill in their individual code, then we can make this clearer in the
next inclusion period. Only employees are included, because civil
servants and self-employed people have other sick leave systems,
which are handled by different authorities in Belgium. The factori-
al validity will be retested in this population sample and the results
will be compared with the population sample in occupational
medicine. 
Validation of the screening instrument
The validation of the screening instrument encompasses six
components: a theoretical construct validation, a criterion valida-
tion (concurrence), a construct validation (factorial), a criterion
(predictive) validity test, a construct (hypothesis) validity test, and
a construct (known- group) validity test. The validation process is
a mixed method approach, since both quantitative and qualitative
research methods are applied. We will discuss all parts of the vali-
dation process below. 
Theoretical construct validation
Theoretical construct validity refers to the degree to which the
instrument fully assesses or measures the construct of interest.6
The development of a content valid instrument is typically
achieved by a rational analysis of the instrument by raters (experts)
familiar with the construct of interest or experts on the research
subject.6 In fact, expert consultation is considered by some to be
the sin qua non of content validity (Messick, 1995).9 According to
Vogt et al., members of the population may also provide useful
input at the item-development stage, as they can review items for
their ease of understanding and relevance to and representativeness
of the construct. Although the term expert has typically been used
to refer to researchers who are knowledgeable in the specific topic
area, members of the population under study may also be consid-
ered experts in some cases.10
To test for theoretical construct validity of the screening instru-
ment in this study, patients will be invited to participate in focus
groups. In total five focus group conversations will take place in
two of the national languages, 3 in Dutch, and two in French.
Consensus techniques, such as the nominal group technique
(NGT), are commonly used with health professionals for develop-
ing clinical practice and setting priorities. The aim of consensus
methods is to determine the degree to which experts agree about a
particular issue. The use of such methods is valuable where una-
nimity of opinion does not exist because of lack of scientific evi-
dence or the complexity of the issue.11
Nominal group technique will be applied to pose the following
questions: 
- What are the major bottlenecks and support needs that you
(have) experience(d) in order to resume work? Patients will
note five issues or opportunities. Afterwards we will categorise
all bottlenecks or opportunities (work-related, person-related,
…). Next, patients are given some time to read the question-
naire instrument that has been developed by the research team. 
- Are there other factors that they want to add now? Are all the
factors that they named in the first phase retrievable in the
questionnaire? 
- Finally, every patient may make a top five of the most impor-
tant factors, that certainly should be questioned, and write it
down on a piece of paper (individually). 
The NGT uses multiple rounds of ranking to achieve consen-
sus and is conducted through face-to-face meetings to facilitate
discussion and consensus-forming. The systematic and democratic
process equalizes decision making among participants and allows
individual opinions to be informed by the community of experts.11
To analyse the results of the focus groups, all recordings will
be transcribed. Then, using NVIVO 11 software, all factors named
by patients will be compared to the factors that are questioned in
the questionnaire. Potential additional factors will be discussed in
the research group. The transcripts will be evaluated by at least two
people of the research group, as well as all focus groups will be
guided by at least two people to prevent for interpretation (mea-
surement) bias.12 Additionally, the scores that the patients gave to
the most important factors will be summed for each outcome
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selected across all participants. A percentage of the maximum pos-
sible score will then be calculated for each outcome [(score from
Round 3 / 15 × number of participants) × 100]. The process of
analysis is described in Sanderson et al.11
The other qualitative data (why are people selecting certain
factors), will be analysed using grounded theory paradigm.
Grounded theory is a general methodology with systematic guide-
lines for gathering and analysing data to generate middlerange
theory. The analytic process consists of coding data; developing,
checking, and integrating theoretical categories; and writing ana-
lytic narratives throughout inquiry. A grounded theory of a studied
topic starts with concrete data and ends with rendering them in an
explanatory theory.13 In this case, we will analyse the specific
motivation of people choosing certain factors as the most impor-
tant, or priorities. These motivations are hidden in the unstructured
data of the transcripts of the Focus groups. Coding these data, we
will try to formulate a theory about why people are prioritizing the
factors in a certain way.   
Construct (factorial) validity 
Factorial validity is an empirical extension of content validity.
This is because it validates the contents of the construct employing
the statistical model called factor analysis. It is usually employed
when the construct of interest is in many dimensions, which form
different domains of a general attribute. In the analysis of factorial
validity, the several items put up to measure a particular dimension
within a construct of interest is supposed to be highly related to one
another than those measuring other dimensions. Construct validity
will be evaluated through a series of confirmatory factor analyses.6
In this study, we will test a hypothesized measurement model for
each category of factors (i.e. work-related factors, functioning,
stressful life-events and person-related factors). Model fit of these
measurement models will be evaluated using the following fit
indices: the Comparative Fit Index (CFI), the Non-Normed Fit
Index (NNFI), the Root Mean Square Error of Approximation
(RMSEA), and the Standardized Root Mean Residual (SRMR).
The χ2 difference test will be applied to compare the hypothesized
measurement model with alternative, nested models. Analyses will
be performed with SPSS 24 and AMOS 24. The analysis will be
performed for two samples, and the results will be compared (for
sample 2 from occupational medicine and sample 3 in insurance
medicine).
Criterion (concurrence) validity
Criterion validity assesses the newly developed questionnaire
against a highly rated existing standard. When the criterion exists
at the same time as the measure, we talk about concurrent validity.6
Path analysis will be applied to investigate the concurrence validi-
ty. We will test multiple models including interrelationships
between the explanatory variables from the patients’ questionnaire
and occupational health physicians’ estimation of patients’ return
to work. In this case, the estimation of the occupational health
physician serves as gold standard for actual return to work, since
this criterion exists at the same time as the questionnaire measure-
ment. Standardized regression weights will be considered signifi-
cant at the 0.05 level. Analyses will be performed with SPSS 24
and AMOS 24.
Criterion (Predictive) validity 
Predictive validity assesses the ability of the questionnaire
(instrument) to forecast future events, behaviour, attitudes or out-
comes. This is assessed using correlation coefficient(6). To test for
predictive validity of the screening tool, the time until work
resumption for every patient will be measured. Survival analysis
will be applied to discover possible relationships between the mea-
sured variables and the time until work resumption. Survival anal-
ysis suits the research question the best, because at the end of the
study period, not all employees will yet have resumed labour, and
some maybe never will. Analysis will be performed using software
R and SPSS 24.  
Construct (Hypothesis testing) validity
Hypothesis testing validity is the evidence that a research hypoth-
esis about the relationship between the measured concept (variable)
or other concepts (variables), derived from a theory, is supported.6 In
this study, we will test different hypothesis using the same dataset as
for the predictive validity test. Statistics from the Belgian organisa-
tion for sickness and disability benefits are giving us the opportunity
to test our prediction model for various hypothesis from which we
know they should be (not) true according to the provided statistics.
Following hypotheses will be tested: i) Psychological problems and
musculoskeletal disorders are the main causes of occupational dis-
ability; ii) Workers are more often absent due to illness than white-
collar workers; iii) Women are more often absent due to illness than
men; iv) Absence due to sickness increases with age. If the screening
tool concludes comparable ideas about these hypotheses stated in sta-
tistical reviews from available data, we could conclude that the
hypothesis testing validity is met. 
Construct (Known group) validity 
In known-group validity, a group with already established
attribute of the outcome of construct is compared to a group in
whom the attribute is not yet established. Since the attribute of the
two groups of respondents is known, it is expected that the mea-
sured construct will be higher in the group with related attribute
but lower in the group with unrelated attribute.6 The known group
validity test will take place using data from another research pro-
ject that examines pain related disability in breast cancer patients.
We will use the completed questionnaires from the cancer patients,
from whom it is known that they generally have a high risk on
long-term sickness absence given their diagnosis. Other informa-
tion (such as participation in return-to work programs) about the
known group will be collected in cooperation with the other
research team. The work resumption prediction of the question-
naire will be evaluated, the same way as we did for the predictive
validity. The same variables will be measured. 
Sample size calculation
Since we are validating the screening tool trough different val-
idation tests, all tests (except for the qualitative research) need the
same sample size calculation. According to power-calculations a
sample size of 269 participants is sufficient within a population of
±400 000 people (± amount of patients in primary sickness absence
in 2013),14 a confidence level of 90% and a margin error of 5%.15
The population that will use our screening tool are the people
who are in sick-leave for six weeks. The population size will be a
little smaller than 400 000 since primary sickness absence starts at
four weeks of sick leave. Sample sizes around 300 will thus be suf-
ficient to conduct our analysis in all validation studies.
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Discussion and Conclusions
The development and validation of a screening instrument to
screen early in the sickness period for risk on long-term sickness
absence is an important study for the Belgian government since it
is trying to reduce long-term sickness absence and promote return-
to work projects. An early screening can help physicians to focus
on high-risk patients who will need their support to resume work.
Since the screening tool is very generic, and makes use of existing
validated instruments, it might be applicable in various internation-
al contexts.
A complete validation of the questionnaire is important to per-
suade all stakeholders involved (patients, physicians, policy mak-
ers, …) of the necessity, and to provide an instrument that is evi-
dence based with proven psychometric value. 
The results of this study might help public health systems to
prevent long-term sickness absence and to support patients more
efficiently in their rehabilitation process. A modern view on pre-
dictors for long-term sickness absence is applied in this research.
Therefore, not only biomedical factors, but also psychosocial items
are questioned in the questionnaire. This means that the results of
the research will help us to gain more insight in the relationships
between biopsychosocial factors and long-term sickness absence.
Strengths in the study design include a combination approach
of different validation methods in different study populations.
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